Aldeyra Therapeutics, Inc.
TREATMENT OF DRY EYE DISEASE
Last updated:
Abstract:
The present invention provides a reproxalap ophthalmic solution, and methods of using the same for treating dry eye disease.
Status:
Application
Type:
Utility
Filling date:
15 Mar 2022
Issue date:
7 Jul 2022